Field-based flow cytometry for ex vivo characterization of plasmodium vivax and P. falciparum antimalarial sensitivity

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 10, 2013, Pages 5170-5174

  Russell, B ^a,b   Malleret, B ^c   Suwanarusk, R ^c   Anthony, C ^b   Kanlaya, S ^d   Lau, Y L ^b   Woodrow, C J ^e,f   Nosten, F ^d,e,f   Renia, L ^c  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b UNIVERSITY OF MALAYA   (Malaysia)

^c AGENCY FOR SCIENCE   (Singapore)

^d SHOKLO MALARIA RESEARCH UNIT   (Thailand)

^e MAHIDOL OXFORD TROPICAL MEDICINE RESEARCH UNIT   (Thailand)

^f UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTESUNATE; CHLOROQUINE; FLUORESCENT DYE; HYDROETHIDINE;

ANTIMALARIAL DRUG SUSCEPTIBILITY; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; EX VIVO STUDY; FLOW CYTOMETRY; GIEMSA STAIN; HUMAN; IC 50; MAJOR CLINICAL STUDY; MICROSCOPY; PARASITEMIA; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PRIORITY JOURNAL;

ANTIMALARIALS; FLOW CYTOMETRY; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX;

EID: 84884256035     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00682-13     Document Type: Article

References (32)

1. Rieckmann KH, Campbell GH, Sax LJ, Mrema JE. 1978. Drug sensitivity of plasmodium falciparum. An in-vitro microtechnique. Lancet i:22-23.
2. Gajanana A, Raichowdhuri AN. 1984. Plasmodium vivax: micro in vitro test for assaying chloroquine susceptibility. Trans. R. Soc. Trop. Med. Hyg. 78:416-417.
3. Renapurkar DM, Pradhan VR, Sutar NK, Deshmukh RA, Pandit CH, Marathe SN. 1989. Micro test for assaying sensitivity of Plasmodium vivax in vitro. Chemotherapy 35:160-163.
4. Basco LK, Le Bras J. 1994. Short-term in vitro culture of Plasmodium vivax and P. ovale for drug-susceptibility testing. Parasitol. Res. 80:262-264.
5. Tasanor O, Noedl H, Na-Bangchang K, Congpuong K, Sirichaisinthop J, Wernsdorfer WH. 2002. An in vitro system for assessing the sensitivity of Plasmodium vivax to chloroquine. Acta Trop. 83:49-61.
6. Russell BM, Udomsangpetch R, Rieckmann KH, Kotecka BA, Coleman RE, Sattabongkot J. 2003. Simple in vitro assay for determining the sensitivity of Plasmodium vivax isolates from fresh human blood to antimalarials in areas where P. vivax is endemic. Antimicrob. Agents Chemother. 47:170-173.
7. Russell B, Suwanarusk R, Malleret B, Costa FT, Snounou G, Baird JK, Nosten F, Renia L. 2012. Human ex vivo studies on asexual Plasmodium vivax: the best way forward. Int. J. Parasitol. 42:1063-1070.
8. Russell B, Chalfein F, Prasetyorini B, Kenangalem E, Piera K, Suwanarusk R, Brockman A, Prayoga P, Sugiarto P, Cheng Q, Tjitra E, Anstey NM, Price RN. 2008. Determinants of in vitro drug susceptibility testing of Plasmodium vivax. Antimicrob. Agents Chemother. 52:1040-1045.
9. Chotivanich K, Udomsangpetch R, Chierakul W, Newton PN, Ruangveerayuth R, Pukrittayakamee S, Looareesuwan S, White NJ. 2004. In vitro efficacy of antimalarial drugs against Plasmodium vivax on the western border of Thailand. Am. J. Trop. Med. Hyg. 70:395-397.
10. Auliff A, Wilson DW, Russell B, Gao Q, Chen N, Anh LN, Maguire J, Bell D, O'Neil MT, Cheng Q. 2006. Amino acid mutations in Plasmodium vivax DHFR and DHPS from several geographical regions and susceptibility to antifolate drugs. Am. J. Trop. Med. Hyg. 75:617-621.
11. Suwanarusk R, Russell B, Chavchich M, Chalfein F, Kenangalem E, Kosaisavee V, Prasetyorini B, Piera KA, Barends M, Brockman A, Lek-Uthai U, Anstey NM, Tjitra E, Nosten F, Cheng Q, Price RN. 2007. Chloroquine resistant Plasmodium vivax: in vitro characterisation and association with molecular polymorphisms. PLoS One 2:e1089. doi:10.1371 /journal.pone.0001089.
12. Sharrock WW, Suwanarusk R, Lek-Uthai U, Edstein MD, Kosaisavee V, Travers T, Jaidee A, Sriprawat K, Price RN, Nosten F, Russell B. 2008. Plasmodium vivax trophozoites insensitive to chloroquine. Malar. J. 7:94.
13. Suwanarusk R, Chavchich M, Russell B, Jaidee A, Chalfein F, Barends M, Prasetyorini B, Kenangalem E, Piera KA, Lek-Uthai U, Anstey NM, Tjitra E, Nosten F, Cheng Q, Price RN. 2008. Amplification of pvmdr1 associated with multidrug-resistant Plasmodium vivax. J. Infect. Dis. 198: 1558-1564.
14. Hasugian AR, Tjitra E, Ratcliff A, Siswantoro H, Kenangalem E, Wuwung RM, Purba HL, Piera KA, Chalfien F, Marfurt J, Penttinen PM, Russell B, Anstey NM, Price RN. 2009. In vivo and in vitro efficacy of amodiaquine monotherapy for treatment of infection by chloroquineresistant Plasmodium vivax. Antimicrob. Agents Chemother. 53:1094-1099.
15. Imwong M, Russell B, Suwanarusk R, Nzila A, Leimanis ML, Sriprawat K, Kaewpongsri S, Phyo AP, Snounou G, Nosten F, Renia L. 2011. Methotrexate is highly potent against pyrimethamine-resistant Plasmodium vivax. J. Infect. Dis. 203:207-210.
16. Rijken MJ, Boel ME, Russell B, Imwong M, Leimanis ML, Phyo AP, Muehlenbachs A, Lindegardh N, McGready R, Renia L, Snounou G, Singhasivanon P, Nosten F. 2011. Chloroquine resistant vivax malaria in a pregnant woman on the western border of Thailand. Malar. J. 10:113.
17. Kaewpongsri S, Sriprawat K, Suwanarusk R, Kyle DE, Lek-Uthai U, Leimanis M, Lwin KM, Phyo AP, Zwang J, Russell B, Nosten F, Renia L. 2011. The presence of leukocytes in ex vivo assays significantly increases the 50-percent inhibitory concentrations of artesunate and chloroquine against Plasmodium vivax and Plasmodium falciparum. Antimicrob. Agents Chemother. 55:1300-1304.
18. Leimanis ML, Jaidee A, Sriprawat K, Kaewpongsri S, Suwanarusk R, Barends M, Phyo AP, Russell B, Renia L, Nosten F. 2010. Plasmodium vivax susceptibility to ferroquine. Antimicrob. Agents Chemother. 54: 2228-2230.
19. Rottmann M, McNamara C, Yeung BK, Lee MC, Zou B, Russell B, Seitz P, Plouffe DM, Dharia NV, Tan J, Cohen SB, Spencer KR, Gonzalez-Paez GE, Lakshminarayana SB, Goh A, Suwanarusk R, Jegla T, Schmitt EK, Beck HP, Brun R, Nosten F, Renia L, Dartois V, Keller TH, Fidock DA, Winzeler EA, Diagana TT. 2010. Spiroindolones, a potent compound class for the treatment of malaria. Science 329:1175-1180.
20. Marfurt J, Chalfein F, Prayoga P, Wabiser F, Kenangalem E, Piera KA, Machunter B, Tjitra E, Anstey NM, Price RN. 2011. Ex vivo drug susceptibility of ferroquine against chloroquine-resistant isolates of Plasmodium falciparum and P. vivax. Antimicrob. Agents Chemother. 55: 4461-4464.
21. Price RN, Marfurt J, Chalfein F, Kenangalem E, Piera KA, Tjitra E, Anstey NM, Russell B. 2010. In vitro activity of pyronaridine against multidrug-resistant Plasmodium falciparum and Plasmodium vivax. Antimicrob. Agents Chemother. 54:5146-5150.
22. Basco LK, Marquet F, Makler MM, Le Bras J. 1995. Plasmodium falciparum and Plasmodium vivax: lactate dehydrogenase activity and its application for in vitro drug susceptibility assay. Exp. Parasitol. 80:260-271.
23. Kosaisavee V, Suwanarusk R, Nosten F, Kyle DE, Barrends M, Jones J, Price R, Russell B, Lek-Uthai U. 2006. Plasmodium vivax: isotopic, PicoGreen, and microscopic assays for measuring chloroquine sensitivity in fresh and cryopreserved isolates. Exp. Parasitol. 114:34-39.
24. Druilhe P, Brasseur P, Blanc C, Makler M. 2007. Improved assessment of Plasmodium vivax response to antimalarial drugs by a colorimetric double-site plasmodium lactate dehydrogenase antigen capture enzymelinked immunosorbent assay. Antimicrob. Agents Chemother. 51:2112-2116.
25. Whaun JM, Rittershaus C, Ip SH. 1983. Rapid identification and detection of parasitized human red cells by automated flow cytometry. Cytometry 4:117-122.
26. Janse CJ, van Vianen PH, Tanke HJ, Mons B, Ponnudurai T, Overdulve JP. 1987. Plasmodium species: flow cytometry and microfluorometry assessments of DNA content and synthesis. Exp. Parasitol. 64:88-94.
27. Pattanapanyasat K, Thaithong S, Kyle DE, Udomsangpetch R, Yongvanitchit K, Hider RC, Webster HK. 1997. Flow cytometric assessment of hydroxypyridinone iron chelators on in vitro growth of drugresistant malaria. Cytometry 27:84-91.
28. Grimberg BT, Erickson JJ, Sramkoski RM, Jacobberger JW, Zimmerman PA. 2008. Monitoring Plasmodium falciparum growth and development by UV flow cytometry using an optimized Hoechst-thiazole orange staining strategy. Cytometry A 73:546-554.
29. Malleret B, Claser C, Ong AS, Suwanarusk R, Sriprawat K, Howland SW, Russell B, Nosten F, Renia L. 2011. A rapid and robust tri-color flow cytometry assay for monitoring malaria parasite development. Sci. Rep. 1:118.
30. Sriprawat K, Kaewpongsri S, Suwanarusk R, Leimanis ML, Lek-Uthai U, Phyo AP, Snounou G, Russell B, Renia L, Nosten F. 2009. Effective and cheap removal of leukocytes and platelets from Plasmodium vivax infected blood. Malar. J. 8:115.
31. Kaddouri H, Nakache S, Houze S, Mentre F, Le Bras J. 2006. Assessment of the drug susceptibility of Plasmodium falciparum clinical isolates from Africa by using a Plasmodium lactate dehydrogenase immunodetection assay and an inhibitory maximum effect model for precise measurement of the 50-percent inhibitory concentration. Antimicrob. Agents Chemother. 50:3343-3349.
32. Le Nagard H, Vincent C, Mentre F, Le Bras J. 2011. Online analysis of in vitro resistance to antimalarial drugs through nonlinear regression. Comput. Methods Programs Biomed. 104:10-18.